Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 4
2003 4
2004 6
2005 5
2006 3
2007 3
2008 4
2009 7
2010 5
2011 4
2012 5
2013 3
2014 11
2015 7
2016 9
2017 4
2018 8
2019 8
2020 6
2021 8
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects.
Bazan-Peregrino M, Garcia-Carbonero R, Laquente B, Álvarez R, Mato-Berciano A, Gimenez-Alejandre M, Morgado S, Rodríguez-García A, Maliandi MV, Riesco MC, Moreno R, Ginestà MM, Perez-Carreras M, Gornals JB, Prados S, Perea S, Capella G, Alemany R, Salazar R, Blasi E, Blasco C, Cascallo M, Hidalgo M. Bazan-Peregrino M, et al. Among authors: alemany r. J Immunother Cancer. 2021 Nov;9(11):e003254. doi: 10.1136/jitc-2021-003254. J Immunother Cancer. 2021. PMID: 35149591 Free PMC article. Clinical Trial.
Systemic cellular viroimmunotherapy for canine high-grade gliomas.
Cloquell A, Mateo I, Gambera S, Pumarola M, Alemany R, García-Castro J, Perisé-Barrios AJ. Cloquell A, et al. Among authors: alemany r. J Immunother Cancer. 2022 Dec;10(12):e005669. doi: 10.1136/jitc-2022-005669. J Immunother Cancer. 2022. PMID: 36600663 Free PMC article.
Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus.
Farrera-Sal M, Moya-Borrego L, Bazan-Peregrino M, Alemany R. Farrera-Sal M, et al. Among authors: alemany r. Clin Cancer Res. 2021 Jun 1;27(11):2979-2988. doi: 10.1158/1078-0432.CCR-20-1565. Epub 2021 Feb 1. Clin Cancer Res. 2021. PMID: 33526422 Review.
Oncolytic Adenoviruses in Cancer Treatment.
Alemany R. Alemany R. Biomedicines. 2014 Feb 21;2(1):36-49. doi: 10.3390/biomedicines2010036. Biomedicines. 2014. PMID: 28548059 Free PMC article. Review.
SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy.
Soto-Castillo JJ, Llavata-Marti L, Fort-Culillas R, Andreu-Cobo P, Moreno R, Codony C, García Del Muro X, Alemany R, Piulats JM, Martin-Liberal J. Soto-Castillo JJ, et al. Among authors: alemany r. Int J Mol Sci. 2023 Jul 6;24(13):11143. doi: 10.3390/ijms241311143. Int J Mol Sci. 2023. PMID: 37446319 Free PMC article. Review.
Oncolytic virotherapy for neuroblastoma.
Ramírez M, García-Castro J, Alemany R. Ramírez M, et al. Among authors: alemany r. Discov Med. 2010 Nov;10(54):387-93. Discov Med. 2010. PMID: 21122470 Free article. Review.
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01.
Pascual-Pasto G, Bazan-Peregrino M, Olaciregui NG, Restrepo-Perdomo CA, Mato-Berciano A, Ottaviani D, Weber K, Correa G, Paco S, Vila-Ubach M, Cuadrado-Vilanova M, Castillo-Ecija H, Botteri G, Garcia-Gerique L, Moreno-Gilabert H, Gimenez-Alejandre M, Alonso-Lopez P, Farrera-Sal M, Torres-Manjon S, Ramos-Lozano D, Moreno R, Aerts I, Doz F, Cassoux N, Chapeaublanc E, Torrebadell M, Roldan M, König A, Suñol M, Claverol J, Lavarino C, Carmen de T, Fu L, Radvanyi F, Munier FL, Catalá-Mora J, Mora J, Alemany R, Cascalló M, Chantada GL, Carcaboso AM. Pascual-Pasto G, et al. Among authors: alemany r. Sci Transl Med. 2019 Jan 23;11(476):eaat9321. doi: 10.1126/scitranslmed.aat9321. Sci Transl Med. 2019. PMID: 30674657 Clinical Trial.
Cancer selective adenoviruses.
Alemany R. Alemany R. Mol Aspects Med. 2007 Feb;28(1):42-58. doi: 10.1016/j.mam.2006.12.002. Epub 2007 Jan 10. Mol Aspects Med. 2007. PMID: 17300834 Review.
109 results